| 1 |
35393909 |
10.1080/09513590.2022.2061454 |
2022 |
Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls. |
MKI67 |
| 2 |
35583604 |
10.1158/1078-0432.CCR-21-3347 |
2022 |
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. |
MKI67 |
| 3 |
33136585 |
10.1097/PAS.0000000000001609 |
2021 |
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. |
MKI67 |
| 4 |
33404293 |
10.1080/15548627.2020.1871204 |
2021 |
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. |
MKI67 |
| 5 |
33941102 |
10.1186/s12885-021-08142-7 |
2021 |
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. |
MKI67 |
| 6 |
32843697 |
10.1038/s41598-020-71058-y |
2020 |
Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy. |
MKI67 |
| 7 |
31219818 |
10.1097/PAS.0000000000001312 |
2019 |
Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. |
MKI67 |
| 8 |
29785709 |
10.1111/bjh.15411 |
2018 |
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL). |
MKI67 |
| 9 |
27959929 |
10.1371/journal.pmed.1002197 |
2016 |
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. |
MKI67 |
| 10 |
25381338 |
10.1158/1078-0432.CCR-14-1913 |
2015 |
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. |
MKI67 |
| 11 |
25648135 |
10.1007/s10549-015-3288-4 |
2015 |
Bcl2 and Ki67 refine prognostication in luminal breast cancers. |
MKI67 |
| 12 |
26546525 |
NA |
2015 |
Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation. |
MKI67 |
| 13 |
21738398 |
NA |
2011 |
Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva. |
MKI67 |
| 14 |
20181625 |
NA |
2010 |
Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. |
MKI67 |
| 15 |
17296585 |
10.3324/haematol.10682 |
2007 |
MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. |
MKI67 |
Datasets
Models
